Background: Preterm birth is a stressful event for both the mother and infant. Whereas the initiation of breastfeeding is important for preterm infant health, little is known of the glucocorticoid hormones (cortisol and cortisone) in human milk following preterm birth. Research aim: The aim of this study was to investigate the relationship between human milk glucocorticoid concentrations and preterm birth. Methods: Human milk was sampled weekly for up to 6 weeks from 22 women who delivered a preterm infant at 28 to 32 weeks' gestation. Human milk was analyzed for total and free cortisol and cortisone concentrations using liquid chromatography-tandem mass spectrometry. Results: Milk sampled from mothers of preterm infants had more cortisone than cortisol (p < .001), with a strong correlation between both hormones (p = .001, r = .85). The cortisone was significantly higher in the milk of mothers who delivered infants after 30 weeks compared with those who delivered before 30 weeks of gestation (p = .02). Glucocorticoid concentrations did not change over the sampling time (weeks 1 to 6 postpartum) and did not differ by infant gender. Conclusion: Glucocorticoids were present in all milk samples following preterm birth. Cortisone concentration tended to be higher in those who delivered after 30 weeks' gestation but did not increase further over the weeks following birth.
Original Research

Background
Preterm birth affects more than 15 million infants worldwide (Blencowe et al., 2013) . These infants are at significantly increased risk of acute adverse health outcomes, with the persistence of lifelong metabolic health complications (Koullali, Oudijk, Nijman, Mol, & Pajkrt, 2016) . The early intake of human milk (HM) confers significant benefits to the health of a preterm infant, with a reduced risk of serious acute events such as sepsis and necrotizing enterocolitis (Herrmann & Carroll, 2014; Patel et al., 2013) . It also improves long-term health with reduced rates of rehospitalization and evidence of protection against metabolic diseases, including diabetes (Menon & Williams, 2013; Underwood, 2013; Vohr et al., 2006) .
There are several unique compositional differences in the HM produced by mothers of preterm infants. Compared with HM produced following term birth, the HM produced after a preterm birth is higher in protein, long chain fatty acids, sodium, and chloride (Gidrewicz et al., 2014; Zhang, Adelman, Rai, Boettcher, & Lönnerdal, 2013) . Beyond simply supplying nutrients, HM also contains a complex array of nonnutritive components. Given the influences of birth gestation and postpartum time on the nutritive composition of HM (Ballard & Morrow, 2013) , it is hypothesized that nonnutritive components may also be altered by degree of infant prematurity.
To date, there are very limited data on the presence of biologically active hormones, including the glucocorticoids (GCs; i.e., cortisol and cortisone), in the milk of mothers who have delivered preterm infants. Based on work by Davis and colleagues (2007) and Grey, Davis, Sandman, and Glynn (2013) , one could infer that GCs transfer from maternal plasma into the milk and, hence, may be influenced by maternal stress. Given that preterm birth is a time of increased maternal stress and anxiety, during and after discharge from the neonatal intensive care unit (Pichler-Stachl et al., 2016) , it is hypothesized that this would impact GC hormone concentrations in the secreted HM.
Currently, there is limited understanding of the psychological and biological importance of GCs in HM. Of the available data, milk-borne GCs are known to influence infant temperament in both animal and human infants (Davis et al., 2007; Grey et al., 2013) . This may, however, be gender specific, as elevated milk GCs were found to be associated with a more confident temperament in mammalian infants but not in females (Sullivan, Hinde, Mendoza, & Capitanio, 2011) . Furthermore, the impact of GCs may extend to influencing infant growth where animal studies demonstrate a relationship between increased levels of milk cortisol and greater infant growth during early and established lactation (Dantzer et al., 2013; Hinde et al., 2015) . To date, one study has demonstrated that very preterm birth (birth at 28 to < 32 weeks' gestation) was associated with reduced HM GC concentrations, relative to term birth (van der Voorn et al., 2016) . However, this study reported only total GCs. It is unknown whether the GCs in HM exist in two forms-free (active) form or bound (inactive) form, which is complexed to either corticosteroid-binding globulin or albumin (Perogamvros, Ray, & Trainer, 2012) . Thus, the present study aimed to examine the impact of birth gestation on GC concentration in HM, the ratio of free to total GCs, and subsequent changes during the postnatal period.
Method
Design
The authors conducted a longitudinal, two-group observational study designed to evaluate the impact of preterm birth severity on milk GC concentrations. The Women and Newborn Health Service and The University of Western Australia ethics committee board reviewed and approved the study protocol with registration number 1749/EW.
Setting
The study was conducted in a large neonatal intensive care unit at Special Care Nurseries of King Edward Memorial Hospital, Perth, Western Australia, the sole tertiary obstetric hospital for the state (Perrella et al., 2015) . The public (government funded) hospital provides services for women from all socioeconomic groups.
Sample
Participants for this study were recruited from the neonatal nurseries of King Edward Memorial Hospital, Western Australia, Australia (Perrella et al., 2015) . The sample for the present study was a subgroup of a larger longitudinal observational study of gastrointestinal function in preterm infants. Convenience sampling was used with no attempts to recruit equal numbers of males and females, as there is no evidence to suggest differences between genders with regard to infant gastrointestinal function.
Stable preterm infants born at 28 to 32 weeks' gestation who were receiving full enteral feeds of mother's own expressed milk or pasteurized donor HM were recruited. Infants with congenital anomalies, gastrointestinal disease, or symptoms of feeding intolerance within the previous 24 hr were excluded. In cases of multiple birth, only one sibling was recruited to the study.
The larger study (from which the participants in the current study were recruited) required weekly monitoring of gastric emptying (two consecutive feeds in the first 3 weeks and single feeds thereafter) until discharge/transfer from the study hospital. Recruitment was paced to meet the capacity to perform the monitoring sessions (3-6 hr duration) and, hence, the longer duration of data collection. No infants were withdrawn from the study. The sample for the present study consisted of 22 women who delivered preterm infants between 28 and 32 weeks. Birth gestation was divided into two groups, according to the equal distribution of sample size in each group. Recorded infant characteristics included birth gestation, birth weight, infant gender, and postnatal age at the time of sample collection.
For sample size, a priori size calculations were conducted using the effect size and variance in fatty acid composition of the HM due to preterm birth as reported by GenzelBoroviczényy, Wahle, and Koletzko (1997) , as previous reports of GCs in preterm birth were not available. Eight participants were required to yield a statistical power of 80%, and 11 were included in each group for possible attrition.
Key Messages
• • Whereas the initiation of breastfeeding is important for preterm infant health, little is known of the glucocorticoid hormones (cortisol and cortisone) in human milk following preterm birth. • • Unlike plasma, human milk demonstrated a higher concentration of cortisone, and the majority of glucocorticoids in milk were in the free form (biologically active) with a strong correlation between cortisol and cortisone. • • Cortisone was lower in the mothers who delivered before 30 weeks of gestation. • • This study provides further insight into the birth gestation impact on milk glucocorticoid composition.
Data Collection
Parents provided written and verbal informed consent prior to milk collection. All HM samples used in the current study were collected using a hospital-grade electric breast pump from February 2011 through April 2013. On the morning of the study, samples were collected from pooled expressed HM, aliquoted into sterile polypropylene-capped tubes, and rapidly stored at −20°C until further analysis (Perrella et al., 2015) . Hormonal analysis of samples was conducted at the Liggins Institute, The University of Auckland, New Zealand, from May 2016 through August 2016.
Measurement
Glucocorticoids were assayed quantitatively from 100 µl of HM with the addition of 100 µl of internal standard. Briefly, the internal standard consisted of 12 ng/ml cortisol d4 and 60 ng/ml corticosterone d8 (Sigma-Aldrich, Darmstadt, Germany), prepared in water. The assay was initiated by warming the milk samples at 37°C for 5 to 7 min and vortexing prior to the addition of the internal standard. Glucocorticoids were extracted using 1 ml ethyl acetate (Merck, Darmstadt, Germany); the top organic layer was removed to a separate tube and then dried in a vacuum drier (Savant SC250EXP; Thermo Fisher Scientific, Asheville, NC, USA) for ~ 2 hr. The dried residues were reconstituted with 80 µl of methanol (Merck) and water (50:50) and transferred to high-performance liquid chromatography (HPLC) injector vials. To detect total and free concentrations of cortisol and cortisone in milk, a different assay was employed. Total GC concentration in milk was detected using a deconjugation enzyme assay. Briefly, 100 µl of warm, vortexed milk was mixed in a glass tube with internal standard (cortisol d4 was used as an internal standard in HM samples). This solution was then buffered with 200 µl of 0.5 N sodium acetate buffer (pH 5.0) and glucuronidase (255 units) enzyme (SigmaAldrich). The solution was incubated at 37°C in a water bath for 3 hr. The enzyme reaction was stopped by heating the tubes at 70°C for 5 min. Then, 1 ml of ethyl acetate (Merck) was added and solution was vortexed for 30 s. The top organic layer was removed, transferred to another glass tube, and dried using a vacuum drier (Savant SC250EXP; Thermo Fisher Scientific). The dried extracts were reconstituted in 80 µl of a mobile phase of methanol (Merck) and water 50:50 and transferred into HPLC vials, 12 µl of the sample were injected into the HPLC mass spectrometer system, and the concentration was analyzed as mentioned above.
The samples were analyzed using a HPLC mass spectrometer system consisting of an Accela MS pump and autosampler, followed by an Ion Max APCI source on a Finnigan TSQ Quantum Ultra AM triple quadrupole mass spectrometer, all controlled by Finnigan Xcalibur software (Thermo Electron Corporation, San Jose, CA, USA). The mobile phase was methanol-water gradient starting at 50:50 (v/v) (peaking at 80:20 before returning to 50:50) at a flow rate of 500 µl/min. The chromatography was performed at 40°C. The following selective reaction monitoring parameters were used: m/z 363.1→121 at 24 V for cortisol, 363.1→163 at 24 V for cortisone, and 367.1→121.0 at 24 V for cortisol d4. To calculate the concentrations of GCs in HM samples, standard curves were generated in blank human plasma spiked with increasing amounts of each steroid: cortisol 0.05-100 ng/ml and cortisone 0.025-50 ng/ml. The area ratio of each steroid to the internal standard was used for quantitation purposes. Steroid concentration in HM was expressed in ng/ml.
Data Analysis
Statistical analyses were performed using Statistical Package for the Social Sciences version 21 (SPSS; IBM Corporation, Armonk, NY, USA). Normality was assessed using ShapiroWilk test; when the assumption of normality was not met, nonparametric tests were used. The differences between GCs (cortisol, cortisone), free to total ratios, and infant gender and birth gestation groups were analyzed using MannWhitney U test. Samples were divided into two groups, according to the equal distribution of sample size in each group; the first group consisted of milk samples from the mothers who delivered before 30 weeks of gestation and the second group consisted of milk samples from mothers who delivered after 30 weeks of gestation. Furthermore, the mixed model was used to investigate the change in milk GC concentrations over the first 6 weeks following birth; infant gender and gestational age were added to the model as covariates. Pearson correlation was used to examine the relationship between cortisol and cortisone concentrations. Data are presented as mean (standard deviation [SD]), unless indicated otherwise. Alpha value was set at p < .05. Graphs were created using Graph Pad Prism version 7.0 (Graph Pad Software, Inc., La Jolla, CA, USA).
Results
Infant Characteristics
Mean (SD) infant birth gestation was 29.9 (1.54) weeks, and infant gender distribution was equal between the two groups with 11 of 22 (50%) males.
Cortisol and Cortisone in Human Milk
All HM samples contained both cortisol (1.88 [1.34] ng/ml) and cortisone (4.48 [1.73] ng/ml). There was a significant positive linear correlation between the cortisol and cortisone concentrations (p = .001, r = .85), as shown in Figure 1 . The free form (biologically available state) accounted for 76.2% of cortisol and 84.2% of cortisone, with less than 30% of both cortisol and cortisone detected in the bound form. The mean (SD) concentration of free cortisol was 1.95 (1.45) ng/ ml and cortisone was 6.58 (1.79) ng/ml, whereas mean (SD) concentration of total cortisol (free and protein bound) was 2.56 (1.78) ng/ml and total cortisone was 7.81 (2.24) ng/ml.
Relationships Between Effect of Gestational Age, Gender and Infant Characteristics, and Human Milk Glucocorticoids
Both mean cortisone concentrations and free to total cortisone ratio were significantly different between birth gestation groups (p = .02 and p = .02, respectively), as shown in Figure 2 . Cortisone concentration was higher in the milk samples of those who delivered at 30 to 32 weeks (5.38 [2.12] ng/ml) compared with those who delivered before 30 weeks' gestation (3.73 [0.99] ng/ml). The HM free to total ratio of cortisone in the < 30 weeks' gestation birth group was 0.94 (0.08) ng/ml, compared with the > 30 weeks' gestation birth group (0.73 [0.20] ng/ml). No significant difference was found between birth gestation groups with regard to HM cortisol concentration and free to total cortisol ratio, with gestational age (p = .82 and p = .95, respectively). However, the mean (SD) cortisol concentration in the milk samples of those who delivered at 30 to 32 weeks was 2.18 (1.79) ng/ml compared with the group who delivered before 30 weeks (1.63 [0.91] ng/ml), whereas free to total ratio of cortisol in the < 30 weeks' gestation birth group was 0.71 (0.24) ng/ml, compared with 0.70 (0.20) ng/ml in the > 30 weeks' gestation birth group. No significant differences were observed between infant gender for the average value of cortisol (p = .15), cortisone (p = .56), and their ratios of free to total cortisol (p = .23) and free to total cortisone (p = .31). Table 1 shows the mean concentrations of hormones in HM by infant gender. Furthermore, the HM concentrations of cortisol (p = .19) and cortisone (p = .48), shown in Figure 3 , and free to total cortisol (p = .66) and free to total cortisone (p = .26) did not change significantly over time (postbirth period ranging from week 1 to week 6 [data not shown]), after being adjusted for infant gender and birth gestation weeks.
Discussion
There is emerging evidence for the role of milk GCs as a regulator of infant growth and behavior development (Dantzer et al., 2013; Hinde et al., 2015) . Yet, little is understood regarding the factors that regulate GC concentrations in HM. In the current study, the free and total concentrations of cortisol and cortisone were measured in HM samples collected from the cohort of women following preterm birth at 28 to 32 weeks' gestation. It was demonstrated that cortisone was the predominant GC and that the majority of both cortisone and cortisol were free. Furthermore, the cortisone concentrations tended to be lower in the HM of mothers who delivered before 30 weeks' gestation but not influenced by the time since birth.
In the current study, the average concentrations of HM cortisol and cortisone were broadly consistent with the prior analysis in preterm HM (van der Voorn et al., 2016) . The predominance of cortisone is also similar to that reported in HM in the 4 weeks following term birth (Pundir et al., 2017; van der Voorn et al., 2016) . Unlike in milk, cortisol is the major GC in adult serum (Hogue, Fry, Fry, & Pressman, 2013; Raff & Trivedi, 2013) . The glandular tissue of the breast converts cortisol into cortisone, presumably via the actions of 11β hydroxysteroid dehydrogenase type 2 enzyme (Chapman, Holmes, & Seckl, 2013; Quirk, Slattery, & Funder, 1990) . The significance of this interconversion, including whether the developing infant has a preferential requirement for milk-derived cortisone, is not yet known. It is interesting that, in this context, higher concentrations of cortisone are found within fetal tissues, also due to the actions of placental 11β hydroxysteroid dehydrogenase type 2 enzyme (Cottrell & Seckl, 2009 ). Furthermore, Giannone, Nankervis, Stenger, Schanbacher, and Bauer (2014) reported the association of cortisone with enhanced intestinal permeability, necrotizing enterocolitis, and thymic activity (greater size thymus in breastfed infants compared with formula fed). Contrary to serum, our results demonstrate a higher concentration of cortisone in milk, but a higher concentration does not imply any significance for infant development. Therefore, further research is required to evaluate the functional significance of GC concentration in breastfed infants.
Preterm infants are reported to have underdeveloped adrenal functioning and an impaired hypothalamic-pituitaryadrenal (HPA) axis response (Finken et al., 2017) , impeding the adequate adrenocorticoid response to stress or illness. However, the HPA axis in preterm infants adapts rapidly, with a recovery of pituitary-adrenal response by the 14th Figure 1 . Demonstrates the correlation between cortisol and cortisone concentration in the milk samples collected from mothers who delivered preterm infants ranging from 28 to 32 weeks of gestational age.
week of postnatal life (Bolt et al., 2002; Ng et al., 2004 ). Yet, emerging evidence suggests that later in life, these infants are predisposed to increased HPA axis activity, which increases their vulnerability to bronchopulmonary dysplasia and cardiovascular instability (Risnes et al., 2016) . The present study demonstrates that GCs in HM are not sufficiently dynamically regulated in relation to the stages of infant development to meet these rapid adaptations in adrenal function. Indeed, the lowest HM concentrations of cortisone were found in mothers who delivered at earlier gestations. These findings could have significant implications for donor milk banks who provide preterm infants with milk from mothers who delivered at term. More research is required to elucidate the potential role of milk-borne GCs in protecting infants against renal adrenal insufficiency.
GCs are lipophilic steroids with a variable proportion bound to large carrier proteins, including corticosteroidbinding globulin or albumin (Perogamvros et al., 2012) . It is generally assumed that the biological activity of GCs is highly dependent on the free concentrations of the hormones in the circulation and these binding proteins are required to mount a normal stress response (Perogamvros et al., 2012) . It has previously been reported that, in blood, bound cortisol accounts for almost 95% of total cortisol (Levine, ZagoorySharon, Feldman, Lewis, & Weller, 2007) . This current study demonstrated that more than 70% of cortisol and cortisone in HM were in their free or hormonally active form. Furthermore, the ratio of free cortisone to total cortisone in HM was higher (0.94) in the milk of mothers who delivered at 30 to 33 weeks' gestation. These findings demonstrate that the free cortisone level increased in comparison with total cortisone, and these ratios may be an index of the maternal adrenal gland (Lee et al., 2014; Morelli et al., 2016; Nomura, Fujitaka, Jinno, Sakura, & Ueda, 1996) . There are very few studies that have measured free to total concentrations of cortisol and cortisone, determined mainly in plasma or urine samples, but little is known about their ratios and the clinical significance of these ratios in HM. However, results of this pilot study could be used to design a future study aimed to further explore the relation between preterm birth and its impact on milk GC concentration and its bioavailability.
Limitations
This study employed a highly sensitive technique to measure GC concentration in HM. The current study also has limitations. Due to the small sample size and single sourced population, these findings cannot be generalized to the entire population. The small sample size, particularly for infants' postnatal age, may limit the ability to identify whether there are gender differences in the milk GC concentration. In addition, the limited clinical and physiological data on both the maternal characteristics and infant birth may have confounded the interpretation of the results. This clearly indicates the need for a larger multicenter study with sampling that can be generalized to the broader population of preterm births. Human milk glucocorticoid concentration, cortisol, cortisone, and their free to total ratio distribution between gestational age groups. Gestational age was categorized into two groups; one group includes milk samples taken from the mother who delivered infants before 30 weeks (< 30 weeks with n = 12) and the other group includes milk from the mothers who delivered infants after 30 weeks' gestation (> 30 weeks with n = 10). The difference between gestational age was expressed as * p < .01. Error bars represent standard error of mean. 
Conclusion
HM from mothers following preterm delivery contains appreciable levels of predominately free (unbound) GCs. It is interesting that cortisone was the predominant GC. Currently, there is a limited understanding of the influence that these GCs have on the health and development of the breastfed infant. However, this study provides further insights into the supply and bioavailability of GCs in HM fed to preterm infants. As our study spans only a short period, further research should focus more on understanding the biological implications of milk-borne GCs on the later life health of an infant.
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